Lauren E. Haydu

Active 2004–2025

79
Papers
22,497
Citations
53
h-index
78
i10-index

Citations

Citations per year for Lauren E. Haydu1971: 1 citations2001: 2 citations2003: 1 citations2004: 15 citations2005: 15 citations2006: 21 citations2007: 12 citations2008: 12 citations2009: 16 citations2010: 23 citations2011: 38 citations2012: 78 citations2013: 100 citations2014: 113 citations2015: 142 citations2016: 111 citations2017: 200 citations2018: 326 citations2019: 1,006 citations2020: 1,360 citations2021: 1,447 citations2022: 1,342 citations2023: 1,108 citations2024: 1,486 citations2025: 906 citations2026: 34 citations1972–2000: no citations, so these years are not shown2002: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,503 citing papers, 25.8% of this breakdownChina: 2,010 citing papers, 14.8% of this breakdownItaly: 737 citing papers, 5.4% of this breakdownUnited Kingdom: 690 citing papers, 5.1% of this breakdownGermany: 684 citing papers, 5% of this breakdownAustralia: 659 citing papers, 4.9% of this breakdownFrance: 628 citing papers, 4.6% of this breakdownNetherlands: 423 citing papers, 3.1% of this breakdownCanada: 396 citing papers, 2.9% of this breakdownSpain: 377 citing papers, 2.8% of this breakdownJapan: 338 citing papers, 2.5% of this breakdownSwitzerland: 319 citing papers, 2.4% of this breakdown
0%25.8%Other 20.7%

Fields

  • Medicine50.9%
  • Biochemistry, Genetics and Molecular Biology37.7%
  • Immunology and Microbiology7.6%
  • Engineering0.7%
  • Computer Science0.6%
  • Agricultural and Biological Sciences0.5%
  • Other2%

Topics

  • Cancer Immunotherapy and Biomarkers13%
  • Gut microbiota and health6.4%
  • Immunotherapy and Immune Responses5.5%
  • Melanoma and MAPK Pathways4.9%
  • Cutaneous Melanoma Detection and Management4.6%
  • CAR-T cell therapy research3.4%
  • Other62.2%

Coauthors

All papers

Open in search
  1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pablo C. Okhuysen, V. Behrana Jensen, Alton G. Swennes, Florencia McAllister, Erick Riquelme, Yexi Zhang, Emmanuelle Le Chatelier, Laurence Zitvogel, Nicolas Pons, Jacob L. Austin-Breneman, Lauren E. Haydu, Elizabeth M. Burton, Julie M. Gardner, Elizabeth Sirmans, Jiemiao Hu, Alexander J. Lazar, Takahiro Tsujikawa, Adi Diab, Hussein A. Tawbi, Isabella C. Glitza, Wen-Jen Hwu, Sapna P. Patel, Scott E. Woodman, Rodabe N. Amaria, Michael A. Davies, Jeffrey E. Gershenwald, Patrick Hwu, J. E. Lee, J. Zhang, Lisa M. Coussens, Zachary A. Cooper, P. Andrew Futreal, Carrie R. Daniel, Nadim J. Ajami, Joseph F. Petrosino, Michael T. Tetzlaff, Padmanee Sharma, James P. Allison, Robert R. Jenq, Jennifer A. Wargo - Science 2017 cited by 4,788

  2. B cells and tertiary lymphoid structures promote immunotherapy response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine N. Spencer, Elizabeth M. Burton, Lauren E. Haydu, Alexander J. Lazar, Roberta Zapassodi, Courtney W. Hudgens, Deborah A. Ledesma, SuFey Ong, Michael Bailey, Sarah Warren, Disha Rao, Oscar Krijgsman, Elisa A. Rozeman, Daniel S. Peeper, Christian U. Blank, Ton N. Schumacher, Lisa H. Butterfield, Monika A. Zelazowska, Kevin M. McBride, Raghu Kalluri, James P. Allison, Florent Petitprez, Wolf H. Fridman, Catherine Sautès‐Fridman, Nir Hacohen, Katayoun Rezvani, Padmanee Sharma, Michael T. Tetzlaff, Linghua Wang, Jennifer A. Wargo - Nature 2020 cited by 2,745

  3. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mohamed A. Jamal, Erez N. Baruch, Eva Pérez‐Guijarro, Chi‐Ping Day, Glenn Merlino, Barbara Pazdrak, Brooke S. Lochmann, Robert Szczepaniak‐Sloane, Reetakshi Arora, Jaime Anderson, Chrystia M. Zobniw, Eliza Posada, Elizabeth Sirmans, Julie M. Simon, Lauren E. Haydu, Elizabeth M. Burton, Linghua Wang, Minghao Dang, Karen Clise-Dwyer, Sarah Schneider, Thomas Chapman, Nana-Ama A.S. Anang, Sheila Duncan, Joseph Toker, Jared Malke, Isabella C. Glitza, Rodabe N. Amaria, Hussein A. Tawbi, Adi Diab, Michael K. Wong, Sapna P. Patel, Scott E. Woodman, Michael A. Davies, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Patrick Hwu, V. Behrana Jensen, Yardena Samuels, Ravid Straussman, Nadim J. Ajami, Kelly C. Nelson, Luigi Nezi, Joseph F. Petrosino, P. Andrew Futreal, Alexander J. Lazar, Jianhua Hu, Robert R. Jenq, Michael T. Tetzlaff, Yan Yan, Wendy S. Garrett, Curtis Huttenhower, Padmanee Sharma, Stephanie S. Watowich, James P. Allison, Lorenzo Cohen, Giorgio Trinchieri, Carrie R. Daniel, Jennifer A. Wargo - Science 2021 cited by 932

  4. Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

    Authors: , , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2017 cited by 2,286

  5. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Khalida Wani, Alexander J. Lazar, Michael T. Tetzlaff, Courtney W. Hudgens, Margaret K. Callahan, Matthew Adamow, Michael A. Postow, Charlotte E. Ariyan, Pierre-Olivier Gaudreau, Luigi Nezi, Didier Raoult, Catalin Mihalcioiu, Arielle Elkrief, Rossanna C. Pezo, Lauren E. Haydu, Julie M. Simon, Hussein A. Tawbi, Jennifer L. McQuade, Patrick Hwu, Wen-Jen Hwu, Rodabe N. Amaria, Elizabeth M. Burton, Scott E. Woodman, Stephanie S. Watowich, Adi Diab, Sapna P. Patel, Isabella C. Glitza, Michael K.K. Wong, Li Zhao, Jianhua Zhang, Nadim J. Ajami, Joseph F. Petrosino, Robert R. Jenq, Michael A. Davies, Jeffrey E. Gershenwald, P. Andrew Futreal, Padmanee Sharma, James P. Allison, Bertrand Routy, Laurence Zitvogel, Jennifer A. Wargo - Nature Medicine 2021 cited by 415

  6. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rodabe N. Amaria, Lawrence N. Kwong, Víctor G. Prieto, R. Eric Davis, Wencai Ma, Willem W. Overwijk, Arlene H. Sharpe, Jianhua Hu, P. Andrew Futreal, Jorge Blando, Padmanee Sharma, James P. Allison, Lynda Chin, Jennifer A. Wargo - Cancer Discovery 2016 cited by 1,008

  7. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liberty Posada, Lauren E. Haydu, Linghua Wang, Shaojun Zhang, Alexander J. Lazar, Courtney W. Hudgens, Vancheswaran Gopalakrishnan, Alexandre Reuben, Miles C. Andrews, Christine N. Spencer, Víctor G. Prieto, Padmanee Sharma, James P. Allison, Michael T. Tetzlaff, Jennifer A. Wargo - Nature Medicine 2018 cited by 826

  8. Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 cited by 415

  9. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul B. Chapman, Jeffrey A. Sosman, Dirk Schadendorf, Jean‐Jacques Grob, Keith T. Flaherty, Dana Walker, Yibing Yan, Edward McKenna, Jeffrey J. Legos, Matteo S. Carlino, Antoni Ribas, John M. Kirkwood, Georgina V. Long, Douglas B. Johnson, Alexander M. Menzies, Michael A. Davies - The Lancet Oncology 2018 cited by 658

  10. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jianjun Zhang, Sheri L. Holmen, Michael T. Tetzlaff, Michael A. Davies - Cancer Discovery 2019 cited by 347

  11. Coenzyme A fuels T cell anti-tumor immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2021 cited by 106

  12. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guang R. Gao, Hiya Banerjee, Mike Lau, Jeffrey E. Gershenwald, Anthony Lucci, Emily Z. Keung, Merrick I. Ross, Laura Pala, Eleonora Pagan, Rossana Lazcano Segura, Qian Liu, Mikayla Borthwick, Eric Lau, Melinda S. Yates, Shannon N. Westin, Khalida Wani, Michael T. Tetzlaff, Lauren E. Haydu, Mikhila Mahendra, Xiao-Yan Ma, Christopher J. Logothetis, Zachary Kulstad, Sarah B. Johnson, Courtney W. Hudgens, Ningping Feng, Lorenzo Federico, Georgina V. Long, P. Andrew Futreal, Swathi Arur, Hussein A. Tawbi, Amy E. Moran, Linghua Wang, Timothy P. Heffernan, Joseph R. Marszalek, Jennifer A. Wargo - Nature 2022 cited by 130

  13. BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact

    Authors: , , , , , , , , , , , , , , , - Clinical Cancer Research 2014 cited by 542

  14. Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 164

  15. Clinical Models to Define Response and Survival With Anti–PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Douglas B. Johnson, Georgina V. Long, Serigne N. Lo, Alexander M. Menzies - Journal of Clinical Oncology 2022 cited by 86

  16. Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma

    Authors: , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 1,047

  17. openalex_id:w4211208194

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Douglas B. Johnson, Georgina V. Long, Serigne Lo, Alexander M. Menzies cited by 77

  18. Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma

    Authors: , , , , , , , , - Clinical Cancer Research 2011 cited by 650

  19. Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fernando C. L. Carapeto, Courtney W. Hudgens, Jason T. Huse, Michael T. Tetzlaff, Elizabeth M. Burton, Hussein A. Tawbi, Michael A. Davies - Nature Medicine 2023 cited by 80

  20. Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF -Mutant Metastatic Melanoma

    Authors: , , , , , , , , - Clinical Cancer Research 2012 cited by 432

  21. The DNA sequence and biology of human chromosome 19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C. Garcı́a, Anca Georgescu, Tijana Glavina, María Gómez‐Ruíz, Eidelyn Gonzales, Matthew Groza, Nancy Hammon, Trevor Hawkins, Lauren E. Haydu, Isaac Ho, Wayne Huang, Sanjay Israni, Jamie Jett, Kristen Kadner, Heather Kimball, Arthur Kobayashi, Vladimer Larionov, Sun‐Hee Leem, Frederick Lopez, Yunian Lou, Steve Lowry, Stephanie Malfatti, Diego Martínez, Paula McCready, Catherine Medina, Jenna Morgan, Kathryn Nelson, Matt Nolan, Ivan Ovcharenko, Sam Pitluck, Martin Pollard, Anthony P. Popkie, Paul Predki, Glenda Quan, Lucı́a Ramı́rez, Sam Rash, James Retterer, Álex Rodríguez, Stephanine Rogers, Asaf Salamov, Angelica Salazar, Xinwei She, Doug Smith, Tom Slezak, Victor Solovyev, Nina Thayer, Hope Tice, Ming Jer Tsai, Anna Ustaszewska, Nu Vo, Mark C. Wagner, Jeremy Wheeler, Kevin Wu, Gary Xie, Joan Yang, Inna Dubchak, Terrence S. Furey, Pieter DeJong, Mark Dickson, David Gordon, Evan E. Eichler, L Pennacchio, Paul Richardson, Lisa Stubbs, Daniel S. Rokhsar, R Myers, Edward M. Rubin, Susan Lucas - Nature 2004 cited by 364

  22. Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 108

  23. Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John F. Thompson, Jeffrey E. Lee, Patrick Hwu, Nadim J. Ajami, Jeffrey E. Gershenwald, Georgina V. Long, Richard A. Scolyer, Michael T. Tetzlaff, Alexander J. Lazar, Dirk Schadendorf, Jennifer A. Wargo, John M. Kirkwood, Ralph J. DeBerardinis, Han Liang, P. Andrew Futreal, Jianhua Zhang, James S. Wilmott, Weiyi Peng, Michael A. Davies, Greg M. Delgoffe, Yana G. Najjar, Jennifer L. McQuade - Clinical Cancer Research 2022 cited by 36

  24. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors

    Authors: , , , , , , , , , , , , - Journal of Clinical Investigation 2014 cited by 174